Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
182.90
+4.80 (2.70%)
Nov 21, 2024, 1:38 PM EST - Market open

Krystal Biotech Revenue

Krystal Biotech had revenue of $83.84M in the quarter ending September 30, 2024, with 879.91% growth. This brings the company's revenue in the last twelve months to $241.52M, up 2,722.80% year-over-year. In the year 2023, Krystal Biotech had annual revenue of $50.70M.

Revenue (ttm)
$241.52M
Revenue Growth
+2,722.80%
P/S Ratio
20.98
Revenue / Employee
$1,054,668
Employees
229
Market Cap
5.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202350.70M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Select Medical Holdings 6.97B
Stevanato Group 1.22B
Waystar Holding 906.14M
Ionis Pharmaceuticals 803.07M
Inspire Medical Systems 755.59M
ADMA Biologics 382.81M
PROCEPT BioRobotics 199.84M
Arcellx 155.82M
Revenue Rankings